Precision Biosciences (DTIL) Operating Income (QoQ) (2018 - 2026)
Precision Biosciences (DTIL) Operating Income (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Precision Biosciences | 178.85 Mn | 150.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -172.55% |
| Dec 31, 2025 | 160.52% |
| Sep 30, 2025 | 5.53% |
| Jun 30, 2025 | 1.06% |
| Mar 31, 2025 | 11.00% |
| Dec 31, 2024 | -16.78% |
| Sep 30, 2024 | -188.11% |
| Jun 30, 2024 | 676.69% |
| Mar 31, 2024 | 71.88% |
| Dec 31, 2023 | -20.44% |
| Sep 30, 2023 | -295.11% |
| Jun 30, 2023 | 76.57% |
| Mar 31, 2023 | -10.28% |
| Dec 31, 2022 | 17.49% |
| Sep 30, 2022 | 50.34% |
| Jun 30, 2022 | -8.12% |
| Mar 31, 2022 | 11.03% |
| Dec 31, 2021 | -166.19% |
| Sep 30, 2021 | -153.36% |
| Jun 30, 2021 | 215.42% |